Sorafenib Teva is indicated for the treatment of:• patients with advanced renal cell carcinoma. • patients with hepatocellular carcinoma• patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.